Outcomes | Misoprostol N (%) | Dinoprostone N (%) | p |
Characteristics of the sample |
| ||
Any personal background | 84 (34.9) | 57 (35.6) | 0.874 |
Obstetric pathology | 103 (42.7) | 78 (48.8) | 0.236 |
Parity Nuliparous Multiparous |
184 (76.3) 57 (23.7) |
129 (80.6) 31 (19.4) | 0.311 |
Maternal age* | 32.1 (4.8) | 31.7 (5.5) | 0.456 |
Gestational age* | 40.1 (1.3) | 39.8 (1.3) | 0.011 |
Reasons for induction |
| ||
Premature membrane rupturing (expectant management) | 85 (35.3) | 27 (16.9) | <0.0001 |
Chronologically prolonged pregnancy | 48 (19.9) | 28 (17.5) | 0.545 |
Pregnancy-related hypertension | 9 (3.7) | 19 (11.9) | 0.002 |
Insuline-dependent GD | 31 (12.9) | 12 (7.5) | 0.089 |
Non insuline-dependent GD | 11 (4.6) | 0 | - |
Maternal decision | 4 (1.7) | 4 (2.5) | 0.556 |
Premature membrane rupturing (active management) | 23 (9.5) | 17 (10.6) | 0.723 |
Intrahepatic cholestasis of pregnancy | 4 (1.7) | 9 (5.6) | 0.028 |
Thrombophilia | 6 (2.5) | 5 (3.1) | 0.703 |
Oligoamnios | 7 (2.9) | 12 (7.5) | 0.034 |
Meconium fluid | 10 (4.1) | 12 (7.5) | 0.344 |
Macrosomia | 1 (0.4) | 0 |
|
Small fetus | 2 (0.8) | 15 (9.4) | <0.0001 |
Bishop score* |
| ||
Initial bishop score* | 2.4 (1.2)* | 2.1 (1.3)* | 0.059 |
Final bishop score* | 6.6 (2.3)* | 6.1 (2.7)* | 0.051 |